We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$22.2B
1-Year Est. Return
58.34%
This Fund
S&P 500
This Quarter
Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
(+15%)
Cap. Flow
-$534M
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$110M |
| 2 |
Entegris
ENTG
|
+$53.1M |
| 3 |
Hilton Worldwide
HLT
|
+$45.7M |
| 4 |
Intuitive Surgical
ISRG
|
+$44.3M |
| 5 |
Western Digital
WDC
|
+$41.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$68.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.3M |
| 3 |
Microsoft
MSFT
|
+$64.1M |
| 4 |
Gilead Sciences
GILD
|
+$63.1M |
| 5 |
ON Semiconductor
ON
|
+$62.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.31% |
| 2 | Healthcare | 24.36% |
| 3 | Financials | 9.42% |
| 4 | Communication Services | 7.08% |
| 5 | Consumer Discretionary | 6.73% |
Similar funds
DCP
TAF
CI
MIM
LF
CIG
ETC
Candriam SCA's Q2 2026 Portfolio in Review
As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
- Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
- Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
- Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
- Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
- Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
- Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
- Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.